| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/23/1997 | WO1996040089A3 Aerosol drug formulations containing vegetable oils |
| 01/23/1997 | WO1996040077A3 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby |
| 01/23/1997 | WO1996040073A3 Composition for sustained release of non-aggregated erythropoietin |
| 01/23/1997 | WO1996040072A3 Composition for sustained release of human growth hormone |
| 01/23/1997 | WO1996031194A3 Skin care compositions containing retinoids and liposomes |
| 01/23/1997 | DE19613698A1 Mittel zur transdermalen Applikation enthaltend Ester des 13-Ethyl-17ß-hydroxy-11-methylen-18,19-dinor-17alpha-pregn-4-en-20-yn-3-ons Means for transdermal administration comprising esters of 13-ethyl-17.beta.-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one |
| 01/23/1997 | DE19526864A1 Hormonpflaster Hormone patches |
| 01/23/1997 | DE19524753A1 Schichttablette zur kontrollierten Freisetzung von Wirkstoffen A layered tablet for the controlled release of active ingredients |
| 01/23/1997 | CA2587000A1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 01/23/1997 | CA2226219A1 Biologically active composition comprising cyclosporine |
| 01/23/1997 | CA2226008A1 Controlled release formulations for poorly soluble drugs |
| 01/23/1997 | CA2225674A1 Therapeutic effervescent compositions |
| 01/23/1997 | CA2222844A1 Water activable adhesive matrix containing amethocaine |
| 01/23/1997 | CA2222372A1 Composition for ph dependent controlled release of active ingredients and methods for producing it |
| 01/22/1997 | EP0754682A1 Aminostilbazole derivative and medicine |
| 01/22/1997 | EP0754465A1 Process for producing sustained-release tablets and enteric tablets |
| 01/22/1997 | EP0754463A2 Stabilized aqueous liquid preparation of blood coagulation factor XIII |
| 01/22/1997 | EP0754456A2 Topical application of ST1435 as a contraceptive agent |
| 01/22/1997 | EP0754453A1 Local anesthetics for topical treatment of headache |
| 01/22/1997 | EP0754452A2 Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract |
| 01/22/1997 | EP0754451A1 Liposome for destroying hiv and cells infected by said virus |
| 01/22/1997 | EP0754450A1 Vitamin-mineral treatment methods and compositions |
| 01/22/1997 | EP0754069A1 Methods for treating pulmonary vasoconstriction and asthma |
| 01/22/1997 | EP0754064A1 An adjunctive polymer system for use with medical device |
| 01/22/1997 | EP0754061A1 New oral pharmaceutical dosage form |
| 01/22/1997 | EP0754055A1 Group a streptococcal polysaccharide immunogenic compositions and methods |
| 01/22/1997 | EP0754049A1 Anti-fungal methods and materials |
| 01/22/1997 | EP0754047A1 Injectable solutions of dirithromycin |
| 01/22/1997 | EP0754045A1 Halofantrine free base for the treatment of malaria and compositions |
| 01/22/1997 | EP0754037A1 Methods of administering n-substituted benzamides or phenothiazines |
| 01/22/1997 | EP0754036A1 Permanently ionic derivatives of steroid hormones and their antagonists |
| 01/22/1997 | EP0754035A1 Carotenoid agent for inhibiting the conversion of epithelial cells to tumours |
| 01/22/1997 | EP0754034A1 Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules |
| 01/22/1997 | EP0754033A1 Heterofunctional, mucoadhesive dosage form |
| 01/22/1997 | EP0754032A1 Liquid delivery compositions |
| 01/22/1997 | EP0754031A1 Multilamellar drug delivery systems |
| 01/22/1997 | EP0754030A1 Method for stabilizing duocarmycin derivatives |
| 01/22/1997 | EP0754006A1 Method and apparatus for diagnosing erectile dysfunction |
| 01/22/1997 | EP0696191B1 Particulate vector and pharmaceutical composition containing such vector |
| 01/22/1997 | EP0659079B1 Transdermal therapeutic system with pentylene tetrazol as active substance |
| 01/22/1997 | EP0615450B1 Dimeticon pastilles |
| 01/22/1997 | EP0593656B1 Novel compositions based on taxane class derivatives |
| 01/22/1997 | EP0550737B1 Controlled release verapamil tablet |
| 01/22/1997 | EP0536235B1 Pressurised aerosol compositions |
| 01/22/1997 | EP0515566B1 Ultrasound enhanced delivery of materials through skin |
| 01/22/1997 | CN2245453Y Vagina hot compress suppository |
| 01/22/1997 | CN1141060A Haemophilus transferrin receptor genes |
| 01/22/1997 | CN1141011A Particulate material |
| 01/22/1997 | CN1140999A Anti-fungal methods and materials |
| 01/22/1997 | CN1140996A Ranitidine and calcium carbonate pharmaceutical combination product |
| 01/22/1997 | CN1140991A Compositions containing micronized nebivolol |
| 01/22/1997 | CN1140990A Transdermal presentation of nitroglycerin for preventing undesived labour |
| 01/22/1997 | CN1140989A Vesicles with controlled release of actives |
| 01/22/1997 | CN1140988A Liquid ophthalmic sustained release delivery system |
| 01/22/1997 | CN1140983A Absorption enhancers for topical pharmaceutical formulations |
| 01/22/1997 | CN1140609A Medicament for nasal administration |
| 01/22/1997 | CN1140608A Dispensing of ointment and drop for rhinitis and preparing method |
| 01/22/1997 | CN1140605A Channel tropism powder |
| 01/22/1997 | CN1140600A Preparation of medicament containing rare-earth for dermatomycosis |
| 01/22/1997 | CN1140597A Preparation for isatis root syrup |
| 01/22/1997 | CN1140596A Ointment for treating burn and scald and promoting tissue regeneration |
| 01/22/1997 | CN1140594A Licorice root preparation series for prevention and cure of liver cancer and restraint of AIDS virus |
| 01/22/1997 | CN1140590A Medicine for episioitis of woman |
| 01/22/1997 | CN1140589A Chewing gum for preventing caries and its prodn |
| 01/21/1997 | US5596011 Administering a glutathione enhancing agent |
| 01/21/1997 | US5595986 Stably storable and readily water soluble composition of cephalosporin for injections |
| 01/21/1997 | US5595980 Contraceptive compositions |
| 01/21/1997 | US5595974 Batroxobin with heparin for cardiovascular disorders |
| 01/21/1997 | US5595971 Prolonged release of biologically active polypeptides |
| 01/21/1997 | US5595764 Calcium carbonate or sulfate dispersed in petrolatum |
| 01/21/1997 | US5595762 Microparticles with protective coatings, drugs, cosmsetics, nutrients, pesticides |
| 01/21/1997 | US5595761 Particulate support matrix for making a rapidly dissolving tablet |
| 01/21/1997 | US5595760 Sustained release of peptides from pharmaceutical compositions |
| 01/21/1997 | US5595759 Steroids such as estrogen or progestin for use as contraceptives |
| 01/21/1997 | US5595758 Soft-shelled gelatin encapsulated particles |
| 01/21/1997 | US5595756 Liposomal compositions for enhanced retention of bioactive agents |
| 01/21/1997 | US5595751 Absorbable polyoxaesters containing amines and/or amido groups |
| 01/21/1997 | US5595747 Slow-releasing compositions containing hydrotalcites which have been intercalated with an organic anion and method of controlling insects and protecting fabric from insects |
| 01/21/1997 | US5595745 Cosmetics; petroleum jelly and behenoyl lactylate salt |
| 01/21/1997 | US5595735 Hemostatic thrombin paste composition |
| 01/21/1997 | US5595728 Amino acid β-lyase enzyme inhibitors as deodorants |
| 01/21/1997 | US5595722 Transforming growth factor-beta activators |
| 01/21/1997 | US5595592 Dye compositions and methods for film coating tablets and the like |
| 01/21/1997 | CA2118133C Aminoguanidine spray drying process |
| 01/21/1997 | CA2098196C Method and systems for administering drugs transdermally using sorbitan esters as skin permeation enhancers |
| 01/21/1997 | CA2089738C Dispensing device containing a hydrophobic medium |
| 01/21/1997 | CA2039518C Cosmetic gel stick compositions |
| 01/21/1997 | CA1338854C Oxygenation of blood substitutes |
| 01/16/1997 | WO1997001357A1 Encapsulated cells producing viral particles |
| 01/16/1997 | WO1997001347A1 Pharmaceutical composition for wound healing |
| 01/16/1997 | WO1997001346A1 Cosmetic or pharmaceutical composition containing an extract of plants of genus filicium, and use of said extract for stimulating glycosaminoglycan synthesis |
| 01/16/1997 | WO1997001345A1 Cosmetic or pharmaceutical composition containing an extract of plants of genus foetidia |
| 01/16/1997 | WO1997001340A1 The combination of topical nasal antihistamines and topical nasal mast cell stabilizers |
| 01/16/1997 | WO1997001337A1 The combination of topical nasal antihistamines and topical nasal steroids |
| 01/16/1997 | WO1997001331A2 Method of producing sustained-release preparation |
| 01/16/1997 | WO1997001329A1 New, stable medicinal compositions for generating propellant-free aerosols |
| 01/16/1997 | WO1997001327A1 Lipophilic and amphiphilic film-forming polymer compositions, and use thereof in topical agents delivery system and method of delivering agents to the skin |
| 01/16/1997 | WO1997001326A1 Stable topical compositions |
| 01/16/1997 | WO1997001324A2 Cosmetic and/or pharmaceutical preparations |
| 01/16/1997 | WO1996036318A3 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application |